Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × elacestrant × Clear all

Phase

Phase 1/2 6 Phase 1 4 Phase 3 2 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 12 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Carboplatin 269 Paclitaxel 267 Gemcitabine 241 Bevacizumab 225 Cisplatin 215 pembrolizumab 211 Docetaxel 209 Pemetrexed 159 Capecitabine 147 Fluorouracil 128 Cyclophosphamide 120 Oxaliplatin 119 Nivolumab 112 Dexamethasone 99 Trastuzumab 89 Leucovorin 86 Cetuximab 84 Rituximab 82 Irinotecan 82 Injections 75 Erlotinib Hydrochloride 70 Prednisone 68 Doxorubicin 68 Temozolomide 67 atezolizumab 65 Ipilimumab 64 Bortezomib 64 Fulvestrant 59 Radiotherapy 54 Drug Therapy 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05596409 2026-04-22

ELCIN

Stemline Therapeutics, Inc.

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡